PubMed:32496122 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":52,"end":60},"obj":"SP_7"},{"id":"T2","span":{"begin":104,"end":120},"obj":"CHEBI:50846"},{"id":"T3","span":{"begin":104,"end":120},"obj":"CHEBI:50846"},{"id":"T4","span":{"begin":136,"end":141},"obj":"CHEBI:23888"},{"id":"T5","span":{"begin":136,"end":141},"obj":"CHEBI:23888"},{"id":"T6","span":{"begin":168,"end":178},"obj":"SP_7"},{"id":"T7","span":{"begin":320,"end":329},"obj":"CL:0002627"},{"id":"T8","span":{"begin":330,"end":342},"obj":"CL:0000094"},{"id":"T9","span":{"begin":347,"end":356},"obj":"CL:0000576"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":330,"end":342},"obj":"Body_part"},{"id":"T2","span":{"begin":347,"end":356},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62854"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62864"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":28,"end":46},"obj":"Disease"},{"id":"T3","span":{"begin":28,"end":38},"obj":"Disease"},{"id":"T4","span":{"begin":39,"end":46},"obj":"Disease"},{"id":"T5","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"T6","span":{"begin":145,"end":163},"obj":"Disease"},{"id":"T8","span":{"begin":145,"end":155},"obj":"Disease"},{"id":"T9","span":{"begin":156,"end":163},"obj":"Disease"},{"id":"T10","span":{"begin":168,"end":176},"obj":"Disease"},{"id":"T11","span":{"begin":179,"end":188},"obj":"Disease"},{"id":"T12","span":{"begin":239,"end":257},"obj":"Disease"},{"id":"T14","span":{"begin":239,"end":249},"obj":"Disease"},{"id":"T15","span":{"begin":250,"end":257},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005101"},{"id":"A2","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009960"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0043839"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005292"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005101"},{"id":"A7","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0009960"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0043839"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005292"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005101"},{"id":"A13","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0009960"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0043839"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005292"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":219,"end":220},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":320,"end":329},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T3","span":{"begin":347,"end":356},"obj":"http://purl.obolibrary.org/obo/CL_0000576"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":104,"end":120},"obj":"Chemical"},{"id":"T2","span":{"begin":136,"end":141},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50846"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":28,"end":46},"obj":"Phenotype"},{"id":"T2","span":{"begin":145,"end":163},"obj":"Phenotype"},{"id":"T3","span":{"begin":239,"end":257},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0100279"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0100279"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0100279"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":14,"end":23},"obj":"Chemical"},{"id":"4","span":{"begin":28,"end":46},"obj":"Disease"},{"id":"5","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"9","span":{"begin":145,"end":163},"obj":"Disease"},{"id":"10","span":{"begin":168,"end":188},"obj":"Disease"},{"id":"11","span":{"begin":239,"end":257},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"MESH:D003093"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:C000657245"},{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"MESH:D003093"},{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"MESH:C000657245"},{"id":"A11","pred":"tao:has_database_id","subj":"11","obj":"MESH:D003093"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":61},"obj":"Sentence"},{"id":"T2","span":{"begin":62,"end":189},"obj":"Sentence"},{"id":"T3","span":{"begin":190,"end":402},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The effect of Adacolumn® on ulcerative colitis with COVID-19.\nCrespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process."}